Ketamine-Like Compound Offers New Hope as a Potential Antidepressant and Non-opioid Painkiller Mar 19, 2019
FDA clears J&J's esketamine in treatment-resistant depression, with restrictions as per REMS Mar 7, 2019
Exclusive Interview: VistaGen CEO Is Passionate About Developing New Treatments for Depression Jan 16, 2019
